Stay updated with breaking news from Study Design. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Updated results from a dataset of 43 patients showed durable responses and stable disease greater than six months with inupadenant monotherapy in five patients with advanced solid tumors, including
Search jobs 04-Jun-2021 iTeos Therapeutics Announces New Phase 1/2a Data Indicating Antitumor Activity of inupadenant, its Adenosine A2A Receptor Antagonist, at ASCO 2021 iTeos Therapeutics Announces New Phase 1/2a Data Indicating Antitumor Activity of inupadenant, its Adenosine A2A Receptor Antagonist, at ASCO 2021 Updated results from a dataset of 43 patients showed durable responses and stable disease greater than six months with inupadenant monotherapy in five patients with advanced solid tumors, including previously reported confirmed partial ...
Clinical Trial Market worth $ 66.17 Billion, Globally, by 2028 at 5.55 % CAGR: Verified Market Research JERSEY CITY, N.J., May 25, 2021 /PRNewswire/ -- Verified Market Research recently published a report, "Clinical Trial Market" By Phase (Phase I, Phase II, Phase III, & Phase IV), By Study Design (Interventional, Observational, & Expanded Access), By Indication (Autoimmune/Inflammation, Pain management, Cardiovascular, CNS condition & Others), and By Geography. According to Verified Market Research, the Global Clinical Trial Market was valued at USD 42.97 Billion in 2020 and is projected to ...
Share this article Share this article ResearchAndMarkets.com's offering. The Global Clinical Trials Market was valued at USD51.25 billion in 2020 and is anticipated to reach USD77.20 billion by 2026, registering a CAGR of 7.10% in the next five years. The market is driven by the outbreak of tropical and infectious diseases such as COVID-19, which has led to extensive clinical trials around the world in order to find the suitable treatment and vaccine. Also, the digitization of clinical trials is anticipated to propel the growth of this market in the coming years. Additionally, the increasi...
Share this article SELBYVILLE, Del., April 19, 2021 /PRNewswire/ -- According to latest report "Clinical Trial Market by Phases (Phase I, Phase II, Phase III, Phase IV), Study Design (Interventional Study, Observational Study, Expanded Access Study), Therapeutic Area (Autoimmune Disease, Oncology, Cardiology, Infectious Disease, Dermatology, Ophthalmology), Regional Outlook, Price Trends, Competitive Market Share & Forecast 2027", by Global Market Insights Inc., the market valuation of clinical trials will cross $59.6 billion by 2027. Major clinical trial market players include Laboratory ...